CVM GFI #198 (VICH GL45) Bracketing and Matrixing Designs For Stability Testing of New Veterinary Drug Substances and Medicinal Products
- Docket Number:
- Issued by:
Guidance Issuing OfficeCenter for Veterinary Medicine
VICH GL3(R), “Stability Testing of New Veterinary Drug Substances and Medicinal Products,” notes that the use of matrixing and bracketing can be applied, if justified, to the testing of new veterinary drug substances and medicinal products, but provides no further guidance on the subject.
This document provides guidance on bracketing and matrixing study designs. Specific principles are defined in this guidance for situations in which bracketing or matrixing can be applied. Sample designs are provided for illustrative purposes, and should not be considered the only, or the most appropriate, designs in all cases.
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2009-D-0309.